Continuous glucose monitoring for insulin therapy in non-ICU patients
Part of Hormones & metabolism clinical trials.
This study tests using a continuous glucose monitor (a small sensor that checks blood sugar all the time) to help guide the dose of insulin given through an IV. This is for patients who are not in the ICU but need insulin therapy for over a day, especially those on steroids or special nutrition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 19 years old.
- You have diabetes (type 1, type 2, or related to pancreatic conditions) or high blood sugar during this hospital stay (above 180 mg/dL) that requires an insulin drip.
- Your insulin drip is expected to continue for more than 24 hours.
- You are not in the intensive care unit (ICU).
- You do not have severe kidney problems (eGFR < 20 or on dialysis).
- You are not pregnant or breastfeeding (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well continuous glucose monitors (small sensors under the skin that track sugar levels) work in ICU patients who need insulin. If you are in the ICU, on insulin, and already have a sensor, you may be able to join.
This study tests whether using a small sensor (continuous glucose monitor) to check your blood sugar while you're in the hospital can improve diabetes management. You'll wear the sensor for a few days and may not need as many finger-prick tests.
This study will look at how well Dexcom continuous glucose monitors (CGMs) work in real life. It helps people with diabetes track their blood sugar levels and may lead to better control of their condition.
This study looks at using a continuous glucose monitor (a small sensor that tracks blood sugar all day) in people with type 2 diabetes who are not taking insulin. It aims to see if using the monitor helps improve blood sugar control.
This study is testing whether using a continuous glucose monitor (a small sensor that tracks blood sugar) in the hospital can help kids with diabetes. It aims to make blood sugar monitoring easier and more effective during a hospital stay.
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.